Its development is driven by the growing body of evidence linking receptor co-activation to enhanced therapeutic efficacy in the management of conditions such as obesity, type 2 diabetes, and metabolic dysfunction
In this multicenter study of over 250,000 hospitalizations, use of novel diabetes medications prior to discharge was rare, raising the concern for systematic underutilization after discharge, Michael Fralick, PhD, MD, MSc, assistant professor in the department of medicine at University of Toronto and clinical scientist at Sinai Health in Toronto, and colleagues wrote
Mustafiz A, Singh AK, Pareek A, Sopory SK, Singla-Pareek SL (2011) Genome-wide analysis of rice and Arabidopsis identifies two glyoxalase genes that are highly expressed in abiotic stresses
Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond